Analysis of Survival in Complete Pathological Response after Long-Course Chemoradiotherapy in Patients with Advanced Rectal Cancer

Analysis of Survival in Complete Pathological Response after Long-Course Chemoradiotherapy in Patients with Advanced Rectal Cancer

Background: Neoadjuvant chemoradiotherapy prior to surgery is the standard treatment for locally advanced rectal cancer. This consists in the patient’s complete pathological response being achieved with no residual tumor presence in the resected specimen, which results in survival improvement. Metho...

Full description

Bibliographic Details
Main Authors:	Cemal Ulusoy, Gülçin Harman Kamalı, Andrej Nikolovski
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Current Oncology
Subjects:	complete pathological response neoadjuvant chemoradiotherapy rectal cancer survival tumor regression grade
Online Access:	https://www.mdpi.com/1718-7729/30/1/81

Similar Items

Factors associated with pathological complete remission after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a real-world clinical setting
by: Minglin Lin, et al.
Published: (2024-08-01)

Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
by: Xiaoying Lou, et al.
Published: (2022-06-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
by: Jianhong Peng, et al.

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
by: N. V. Severskaya, et al.
Published: (2018-11-01)

A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Wenjing Peng, et al.
Published: (2023-08-01)

Prediction of Survival Status of Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy Based on Improved Fully Convolutional Networks Model
by: WANG Fang, et al.
Published: (2022-07-01)

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
by: Min Jung Kim, et al.
Published: (2023-08-01)

results of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Comparative efficiency of hypofractionation and classical fractionation schedules
by: A. S. Abdujapparov, et al.
Published: (2020-08-01)

Complete pathological response following neoadjuvant chemoradiotherapy in locally advanced colorectal carcinoma
by: Ozana Miličević, et al.
Published: (2022-01-01)

Short-Term Clinical and Oncological Outcome of Prolonging Operation Interval After Neoadjuvant Chemoradiotherapy for Locally Advanced Middle and Low Rectal Cancer
by: Yang J, et al.
Published: (2020-03-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study
by: Xiaoxue Huang, et al.
Published: (2023-03-01)

Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Yu-Ning Pan, et al.
Published: (2024-07-01)

Factors associated with higher rate of Complete Pathologic Response after Long-Course Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients – Results from a retrospective cohort study focused on Inflammatory Indexes
by: Carlos Cerdan-Santacruz, et al.
Published: (2021-09-01)

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
by: I-Li Lai, et al.
Published: (2023-07-01)

Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran
by: Hadi Ahmadi Amoli, MD, et al.
Published: (2022-12-01)

Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials
by: Wenji Pu, et al.
Published: (2024-12-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.

A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer
by: Guancong Wang, et al.
Published: (2024-06-01)

An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
by: Supparerk Laohawiriyakamol, et al.
Published: (2023-02-01)

Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials
by: Wenji Pu, et al.
Published: (2025-01-01)

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
by: Yu-Hsuan Kuo, et al.
Published: (2022-12-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?
by: Alexander Grabenbauer, et al.
Published: (2023-01-01)

Clinico-pathological predictors of clinical complete response in rectal cancer
by: P. Mbanu, et al.
Published: (2022-01-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
by: Quoc Riccardo Bao, et al.
Published: (2022-09-01)

Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)
by: Felix J. Hüttner, et al.
Published: (2018-01-01)

Review and prospect of neoadjuvant chemoradiotherapy combined with immunotherapy in locally advanced rectal cancer
by: WANG Yaqi, XIA Fan, ZHANG Zhen
Published: (2024-05-01)

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
by: Amine Souadka, et al.
Published: (2019-10-01)

Is clinical complete response as accurate as pathological complete response in patients with mid-low locally advanced rectal cancer?
by: Niyaz Shadmanov, et al.
Published: (2025-02-01)

Laparoscopic total pelvic exenteration after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Chu-Ying Wu, et al.
Published: (2022-11-01)

Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Xinyu Shi, et al.
Published: (2022-08-01)

Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy
by: Rong Wang, et al.
Published: (2022-06-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy
by: Hakkı Çelik, et al.
Published: (2023-03-01)

Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Jianguo Yang, et al.
Published: (2023-11-01)